$6.69
0.253.88%
Last update: Nov 3, 11:07 AM
Emergent BioSolutions Inc (EBS) Stock Price, Quote, News & History
EBSNYSE
U.S. futures mixed as Adeia plunges 23% after missing Q3 estimates and cutting FY26 guidance; Bioventus, Emergent and others also fall premarket.
You can purchase shares of Emergent BioSolutions (NYSE:EBS) through any online brokerage.
Other companies in Emergent BioSolutions’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Emergent BioSolutions has a consensus price target of $13.50.
The stock price for Emergent BioSolutions (NYSE: EBS) is $6.69 last updated November 3, 2026 at 11:07 AM EST.
There are no upcoming dividends for Emergent BioSolutions.
Emergent BioSolutions does not have any upcoming earnings scheduled.
There is no upcoming split for Emergent BioSolutions.
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal...
